Clinical trials
Rectal Neoplasms trials in Egypt
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2008 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Unknown status | 8 |
| Recruiting | 3 |
| Not yet recruiting | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mansoura University | 7 |
| Assiut University | 3 |
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| Ain Shams University | 2 |
| Alexandria University | 2 |
| Sohag University | 2 |
| South Valley University | 2 |
| Amany sayed Abass | 1 |
| Menoufia University | 1 |
| Osama Mohammad Ali ElDamshety | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rectal Neoplasms | 26 |
| Colorectal Neoplasms | 6 |
| Colonic Neoplasms | 5 |
| Anastomotic Leak | 2 |
| Irritable Bowel Syndrome | 1 |
| Neoplasm Metastasis | 1 |
| Neoplasms | 1 |
| Postoperative Complications | 1 |
| Prostatic Neoplasms | 1 |
| Recurrence | 1 |
Trials
Showing 51 to 26 of 26. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.